TuisGUD • TSE
add
Knight Therapeutics Inc
Vorige sluiting
$7,44
Dagwisseling
$7,41 - $7,50
Jaarwisseling
$5,43 - $7,50
Markkapitalisasie
730,36 m CAD
Gemiddelde volume
92,79 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
TSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 133,11 m | 37,42% |
Bedryfskoste | 58,51 m | 35,10% |
Netto inkomste | 8,85 m | -17,52% |
Netto winsgrens | 6,65 | -39,98% |
Wins per aandeel | 0,10 | -4,73% |
EBITDA | 16,47 m | 154,91% |
Effektiewe belastingkoers | 21,12% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 114,23 m | -33,91% |
Totale bates | 1,05 mjd | 8,56% |
Totale aanspreeklikheid | 279,03 m | 65,41% |
Totale ekwiteit | 767,27 m | — |
Uitstaande aandele | 98,03 m | — |
Prys om te bespreek | 0,96 | — |
Opbrengs op bates | 1,48% | — |
Opbrengs op kapitaal | 1,81% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 8,85 m | -17,52% |
Kontant van bedrywe | 34,87 m | 2 273,86% |
Kontant van beleggings | -4,58 m | -125,40% |
Kontant van finansiering | -34,80 m | -126,64% |
Netto kontantverandering | -5,43 m | -185,45% |
Beskikbare kontantvloei | 33,32 m | 571,65% |
Meer oor
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Gestig
2014
Hoofkwartier
Webwerf
Werknemers
830
